1. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
   Raefa Abou Khouzam et al, 2023, Seminars in Cancer Biology CrossRef
2. Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)
   David J. Thomson et al, 2023, International Journal of Radiation Oncology*Biology*Physics CrossRef
3. Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response
   Tim A. D. Smith, 2024, Genes CrossRef